Barricaid is one of the most studied devices in spine.
- Level 1 RCT with 5 year follow up
- FDA PMA Approved
- 8,000+ implantations
- 65+ peer reviewed publications
- Proven superior vs. discectomy alone:
significant reduction in reherniations,
reoperations, and readmissions
7 Published Studies, 81% reduction in rate of reoperation to treat reherniation
|RCT 1: Thomé, 20181||72%|
|RCT 2: Cho, 20192||83%|
|Weighted Average §||81%|
- Thomé C, Klassen PD, Bouma GJ, et al.
Annular closure in lumbar microdiscectomy for prevention of reherniation: a randomized clinical trial.
Spine J. 2018 Dec;18(12):2278-2287. doi: 10.1016/j.spinee.2018.05.003. Epub 2018 May 3.
- Cho PG, Shin DA, Park SH, Ji GY
Efficacy of a Novel Annular Closure Device after Lumbar Discectomy in Korean Patients : A 24-Month Follow- Up of a Randomized Controlled Trial
J Korean Neurosurg Soc 62 (6) : 691-699, 2019; doi.org/10.3340/jkns.2019.0071
- Vukas D, Ledić D, Grahovac G, Kolić Z, Rotim K, Vilendečić M
Clinical Outcomes In Patients After Lumbar Disc Surgery With Anular Reinforcement Device; Two-Year Follow Up.
Acta Clin Croat (2013) 52:87-91
- Lequin M, Barth M, Thomé C, Bouma GJ
Primary Limited Lumbar Discectomy with an Annulus Closure Device: One-Year Clinical and Radiographic Results from a Prospective, Multi-Center Study. Korean J Spine (2012) 9(4):340-347
- Ardeshiri A, Miller LE, Synowitz M, Jadik S
Surgical Experience and Complications in 50 Patients Treated with an Anular Closure Device Following Lumbar Discectomy. Orthop Surg. 2019 Jun;11(3):431-437. doi: 10.1111/os.12495
- Kuršumović A, Rath S
Performance Of An Annular Closure Device In A ‘Real-World’, Heterogeneous, At-Risk, Lumbar Discectomy Population. Cureus. 2017;9:e1824.
- Sanginov AJ, Krutko AV, Baykov ES, et al.
Outcomes of surgical treatment of lumbar disk herniation using an annular closure device. Coluna/Columna. 2018;17:188–194.
*Some studies outside US indications. Values at Minimum 1 year Post-Op.
*Single arm studies are compared to a published cohort of primary discectomy only subjects with large annular defects. Values are reported at one year post-op, unless otherwise indicated.
§ Weighting based on number of Barricaid implants in study at that timepoint.
§ Some of the referenced studies include data from implant sizes not available in the United States or from use of the Barricaid outside of the United States indications for use.
For full benefit/risk information, visit www.barricaid.com/instructions.